SPL 0.00% $1.16 starpharma holdings limited

Buyout reasons for

  1. 1,899 Posts.
    lightbulb Created with Sketch. 69
    So dep/irn shows more outstanding results as detailed in AB's large post, dep/dox well into phase 3 still no side effects and dep/ cab started phase 1/2 . I am pretty sure the large Pharmas are not going to put up with having to pay hundreds of millions for each licence then milestones and royalties for decades for each drug they want, these big boys just don't do that. However they are not going to sit back and watch Starpharma licence to generic makers or even the Chinese, sooner or later one of them has to make a move imo. Starpharma are close to being able to sell dep/dox is this the starting gun for an offer? I am hoping so.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Mkt cap ! $431.1M
Open High Low Value Volume
$1.17 $1.18 $1.15 $279.5K 240.9K

Buyers (Bids)

No. Vol. Price($)
1 121 $1.16

Sellers (Offers)

Price($) Vol. No.
$1.17 1878 1
View Market Depth
Last update - 16.10pm 17/09/2019 (20 minute delay) ?
0.000 ( 0.47 %)
Open High Low Volume
$1.17 $1.18 $1.16 37829
Last updated 15.59pm 17/09/2019 (live) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.